2010Zhongguo yaofangRequires access

Clinical Efficacy Analysis of Amlodipine in the Treatment of Primary Hypertension

Liqin Zhu, LI Jing-yong

Open publisher page 0 citations

Abstract

OBJECTIVE:To analyze clinical efficacy and safety of amlodipine in the treatment of primary hypertension.METHODS:76 patients with primary hypertension were randomly divided into control group(n=35) and treatment group(n=41).Control group were treated with captopril 12.5 mg once a day and treatment group were given amlodipine 5 mg once a day.The change of blood pressure was recorded during treatment.Blood pressure index at 10th day before and after treatment were used to evaluate clinical efficacy.RESULTS:After treatment systolic blood pressure and diastolic blood pressure were significantly decreased,there was significant difference before and after treatment(P0.01);the decrease of systolic blood pressure in treatment group was smaller than in control group while there had no significant difference.In control group effective rate was 28.57% and total response rate was 57.14%.In treatment group effective rate was 75.61% and total response rate was 87.80%.There were significant difference in effective rate and total response rate between two groups(P0.01).CONCLUSION:Amlodipine is superior to captopril in the treatment of primary hypertension.

About this research paper

What this paper is about

OBJECTIVE:To analyze clinical efficacy and safety of amlodipine in the treatment of primary hypertension.METHODS:76 patients with primary hypertension were randomly divided into control group(n=35) and treatment group(n=41).Control group were treated with captopril 12.5 mg once a day and treatment group were given amlodipine 5 mg once a day.The change of blood pressure was recorded during treatment.Blood pressure index at 10th day before and after treatment were used to evaluate clinical efficacy.RESULTS:After treatment systolic blood pressure and diastolic blood pressure were significantly decreased,there was significant difference before and after treatment(P0.01);the decrease of systolic blood pressure in treatment group was smaller than in control group while there had no significant difference.In control group effective rate was 28.57% and total response rate was 57.14%.In treatment group effective rate was 75.61% and total response rate was 87.80%.There were significant difference in effective rate and total response rate between two groups(P0.01).CONCLUSION:Amlodipine is superior to captopril in the treatment of primary hypertension.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To analyze clinical efficacy and safety of amlodipine in the treatment of primary hypertension.METHODS:76 patients with primary hypertension were randomly divided into control group(n=35) and treatment group(n=41).Control group were treated with captopril 12.5 mg once a day and treatment group were given amlodipine 5 mg once a day.The change of blood pressure was recorded during treatment.Blood pressure index at 10th day before and after treatment were used to evaluate clinical efficacy.RESULTS:After treatment systolic blood pressure and diastolic blood pressure were significantly decreased,there was significant difference before and after treatment(P0.01);the decrease of systolic blood pressure in treatment group was smaller than in control group while there had no significant difference.In control group effective rate was 28.57% and total response rate was 57.14%.In treatment group effective rate was 75.61% and total response rate was 87.80%.There were significant difference in effective rate and total response rate between two groups(P0.01).CONCLUSION:Amlodipine is superior to captopril in the treatment of primary hypertension.

Key concepts: Amlodipine, Medicine, Blood pressure, Captopril, Clinical efficacy, Significant difference, Treatment and control groups, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Efficacy Analysis of Amlodipine in the Treatment of Primary Hypertension — Research Paper | ScholarLens